secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ardent Health, Inc. (ARDT)
CIK:        0001756655
Form:       8-K
Filed at:   2026-06-02T20:23:36+00:00
Accession:  0001193125-26-253567
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardent Health appoints Dave Caspers as CEO, reaffirms FY 2026 EBITDA guidance
-----------------------------------------------------------------------------

- Dave Caspers appointed President and CEO, effective June 2, 2026, succeeding Marty Bonick.
- Caspers receives $900k base salary, 105% target bonus, RSUs ($1.05M) and PRSUs ($1.95M target).
- Company reaffirms FY 2026 Adjusted EBITDA guidance of $485M-$535M despite Q2 volume softness.
- CFO says Q2 volume softness observed; IMPACT program accelerated to improve margins.
- Caspers also appointed to Board of Directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756655/000119312526253567/0001193125-26-253567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756655/000119312526253567/d854796d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-253567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer